血清多项肿瘤标志物联合检测在结直肠癌早期诊断中的价值
The Value of Combined Detection of Multiple Serum Tumor Markers in the Early Diagnosis of Colorectal Cancer
摘要: 目的:探讨血清肿瘤标志物癌胚抗原(CEA)、糖类抗原199 (CA199)、糖类抗原724 (CA724)联合检测在结直肠癌诊断中的价值。方法:选取2023年1月至2024年12月期间于北华大学附属医院首次诊治的结直肠癌患者50例作为观察组,另选取同期结直肠良性病变患者50例作为对照组。检测并比较两组患者血清CEA、CA199、CA724水平。由于数据呈偏态分布,以中位数(四分位数间距)描述,组间比较采用Mann-Whitney U检验。分析上述指标单独与联合检测对结直肠癌的诊断效能。结果:观察组血清CEA、CA199、CA724水平中位数均显著高于对照组。多因素Logistic回归分析显示,血清CEA、CA199、CA724水平升高均是发生结直肠癌的独立危险因素(均P < 0.05),其中CA724的预测能力最强(OR = 1.24, 95% CI: 1.10~1.40)。联合检测的敏感度(91.11%)和AUC值(0.941)均显著高于任一单项检测。结论:血清CEA、CA199、CA724均可作为诊断结直肠癌的辅助生物学指标,三者联合检测可显著提高诊断敏感度,对结直肠癌高危人群的筛查具有一定意义。
Abstract: Objective: To evaluate the diagnostic value of the combined detection of serum tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen 199 (CA199), and carbohydrate antigen 724 (CA724) in colorectal cancer (CRC). Methods: A total of 50 patients with initially diagnosed CRC at the Affiliated Hospital of Beihua University from January 2023 to December 2024 were enrolled as the observation group, along with 50 patients with benign colorectal lesions during the same period as the control group. Serum levels of CEA, CA199, and CA724 were measured and compared between the two groups. As the data were skewed, they were described using the median (interquartile range), and the Mann-Whitney U test was used for group comparisons. The diagnostic efficacy of individual and combined detection for CRC was analyzed. Results: The median levels of serum CEA, CA199, and CA724 in the observation group were significantly higher than those in the control group. Multivariate Logistic regression analysis identified elevated serum CEA, CA199, and CA724 as independent risk factors for CRC (all P < 0.05), with CA724 demonstrating the strongest predictive capability (OR = 1.24, 95% CI: 1.10~1.40). The combined detection showed significantly higher sensitivity (91.11%) and a larger area under the curve (AUC = 0.941) than any single marker alone. Conclusion: Serum CEA, CA199, and CA724 can serve as auxiliary biological indicators for diagnosing CRC. Their combined detection significantly improves diagnostic sensitivity and holds potential value for screening high-risk populations.
文章引用:吴奇, 杨学良, 林泽楷. 血清多项肿瘤标志物联合检测在结直肠癌早期诊断中的价值[J]. 临床医学进展, 2025, 15(12): 881-890. https://doi.org/10.12677/acm.2025.15123482

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] 周雄, 胡明, 李子帅, 等. 2020年全球及中国结直肠癌流行状况分析[J]. 海军军医大学学报, 2022, 43(12): 1356-1364.
[3] 樊代明, 李耕. 近几年发现的向种消化系肿瘤标志物[J]. 实用肿瘤杂志, 1994, 9(4): 196.
[4] 国家卫生健康委员会医政司, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2023版) [J]. 协和医学杂志, 2023, 14(4): 706⁃733.
[5] Attallah, A., El-Far, M., Ibrahim, A., El-desouky, M., Omran, M., Elbendary, M., et al. (2018) Clinical Value of a Diagnostic Score for Colon Cancer Based on Serum CEA, CA19-9, Cytokeratin-1 and Mucin-1. British Journal of Biomedical Science, 75, 122-127. [Google Scholar] [CrossRef] [PubMed]
[6] 李萍, 杨丰梅, 刘慧, 等. 4项血清肿瘤标志物水平对结肠癌诊断与预后的价值[J]. 实用医药杂志, 2021, 38(2): 129-131.
[7] 崔连鸷, 翟悦, 张晓伟, 等. 血清GP73、CEA及CA7-24在结肠癌诊断中的价值探讨[J]. 中国卫生工程学, 2023, 22(6): 752-754.
[8] 钟武, 张磊昌, 钟世彪, 等. 结直肠癌患者术前CEA、CA19-9浓度与临床病理特征及预后的关系[J]. 中国普通外科杂志, 2015, 24(4): 499-504.
[9] Klein, C., Waldhauer, I., Nicolini, V.G., Freimoser-Grundschober, A., Nayak, T., Vugts, D.J., et al. (2017) Cergutuzumab Amunaleukin (CEA-IL2V), a CEA-Targeted IL-2 Variant-Based Immunocytokine for Combination Cancer Immunotherapy: Overcoming Limitations of Aldesleukin and Conventional Il-2-Based Immunocytokines. OncoImmunology, 6, e1277306. [Google Scholar] [CrossRef] [PubMed]
[10] El-Magied, M.H.A., Fawzy, A., Mostafa, M.M., Elnaggar, G.N., Moselhy, S.S. and Elhady, M.M. (2025) Alterations in Expression of Mirna 497 and Long Non-Coding RNAS (XIST-TSIX) and Its Significant Role in Colorectal Cancer Prediction. Scientific Reports, 15, Article No. 7387. [Google Scholar] [CrossRef] [PubMed]
[11] Liu, X., Sun, K., Zhu, H., Dai, Y. and Liu, X. (2024) Diagnostic and Prognostic Value of Double-Negative T Cells in Colorectal Cancer. Heliyon, 10, e34645. [Google Scholar] [CrossRef] [PubMed]
[12] Huang, D., Lin, Q., Song, J. and Xu, B. (2021) Prognostic Value of Pretreatment Serum CA199 in Patients with Locally Advanced Rectal Cancer Treated with CRT Followed by TME with Normal Pretreatment Carcinoembryonic Antigen Levels. Digestive Surgery, 38, 24-29. [Google Scholar] [CrossRef] [PubMed]
[13] He, W., Yang, Y., Liu, Q., Luo, D., Li, Q. and Li, X. (2024) Conditional Survival and the Prognostic Value of Serum Carcinoembryonic Antigen Level in Oldest Old with Colorectal Cancer. BMC Gastroenterology, 24, Article No. 220. [Google Scholar] [CrossRef] [PubMed]
[14] Enblad, M., Cashin, P., Ghanipour, L. and Graf, W. (2025) Patterns of Preoperative Tumor Markers Can Predict Resectability and Prognosis of Peritoneal Metastases: A Clustering Analysis. Annals of Surgical Oncology, 32, 3638-3647. [Google Scholar] [CrossRef] [PubMed]
[15] Song, J., Jin, Y., Fan, S., Wei, Y., Dong, D., Jia, L., et al. (2024) CDH3 Is an Effective Serum Biomarker of Colorectal Cancer Distant Metastasis Patients. Journal of Cancer, 15, 5218-5229. [Google Scholar] [CrossRef] [PubMed]
[16] Cao, Y., Efetov, S.K., He, M., Fu, Y., Beeraka, N.M., Zhang, J., et al. (2023) Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer. Archivum Immunologiae et Therapiae Experimentalis, 71, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
[17] Xu, Y., Zhang, P., Zhang, K. and Huang, C. (2021) The Application of CA72-4 in the Diagnosis, Prognosis, and Treatment of Gastric Cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1876, Article 188634. [Google Scholar] [CrossRef] [PubMed]
[18] Zhou, C. and Zhao, S. (2024) Evaluation of the Value of Combined Detection of Tumor Markers CA724, Carcinoembryonic Antigen, CA242, and CA19-9 in Gastric Cancer. World Journal of Gastrointestinal Oncology, 16, 1737-1744. [Google Scholar] [CrossRef] [PubMed]
[19] Zhao, Y., Han, J., Yang, R., Wang, S., Zhao, X., Wang, Z., et al. (2025) Evaluating the Predictive Significance of D-Dimer in Conjunction with CA724 for the Postoperative Outcomes in Gastric Cancer: A Retrospective Cohort Analysis. PLOS ONE, 20, e0320193. [Google Scholar] [CrossRef] [PubMed]
[20] Zhang, H., Lin, F. and Wang, Z. (2023) Mean Platelet Volume/Platelet Count Ratio in Combination with Tumor Markers in Colorectal Cancer: A Retrospective Clinical Study. BMC Cancer, 23, Article No. 124. [Google Scholar] [CrossRef] [PubMed]
[21] 高显华, 赵子夜, 刘连杰, 等. 林奇综合征的筛查和诊治研究进展[J]. 结直肠肛门外科, 2023, 29(2): 115-121.
[22] Sinicrope, F.A. (2018) Lynch Syndrome-Associated Colorectal Cancer. New England Journal of Medicine, 379, 764-773. [Google Scholar] [CrossRef] [PubMed]
[23] Bruner, L.P., White, A.M. and Proksell, S. (2023) Inflammatory Bowel Disease. Primary Care: Clinics in Office Practice, 50, 411-427. [Google Scholar] [CrossRef] [PubMed]
[24] Zhang, Y. (2014) Inflammatory Bowel Disease: Pathogenesis. World Journal of Gastroenterology, 20, 91-99. [Google Scholar] [CrossRef] [PubMed]